blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3193629

EP3193629 - ANTI-DIARRHEA FORMULATION WHICH AVOIDS ANTIMICROBIAL RESISTANCE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.12.2023
Database last updated on 30.09.2024
FormerThe patent has been granted
Status updated on  23.12.2022
FormerGrant of patent is intended
Status updated on  21.09.2022
FormerExamination is in progress
Status updated on  19.06.2020
FormerRequest for examination was made
Status updated on  23.06.2017
FormerThe international publication has been made
Status updated on  13.03.2017
Most recent event   Tooltip02.08.2024Lapse of the patent in a contracting state
New state(s): BE		published on 04.09.2024  [2024/36]
Applicant(s)For all designated states
Anatara Lifesciences Limited
433 Logan Road
Stones Corner
Brisbane, QLD 4120 / AU
[2017/30]
Inventor(s)01 / MYNOTT, Tracey L.
32 Kingsholme Street
Tenerife
QLD 4005 / AU
02 / WALSH, John
5 Stirgess Ave, Curl Curl
Sydney, New South Wales 2096 / AU
 [2017/48]
Former [2017/30]01 / MYNOTT, Tracey L.
433 Logan Road
Stones Corner
Brisbane, QLD 4120 / AU
02 / WALSH, John
5 Stirgess Ave, Curl Curl
Sydney, New South Wales 2096 / AU
Representative(s)Haseltine Lake Kempner LLP
One Portwall Square
Portwall Lane
Bristol BS1 6BH / GB
[2023/04]
Former [2017/30]Brown, David Leslie
Haseltine Lake LLP
Redcliff Quay
120 Redcliff Street
Bristol BS1 6HU / GB
Application number, filing date15836374.724.08.2015
[2017/30]
WO2015US46509
Priority number, dateUS201462041175P25.08.2014         Original published format: US 201462041175 P
[2017/30]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016032944
Date:03.03.2016
Language:EN
[2016/09]
Type: A1 Application with search report 
No.:EP3193629
Date:26.07.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 03.03.2016 takes the place of the publication of the European patent application.
[2017/30]
Type: B1 Patent specification 
No.:EP3193629
Date:25.01.2023
Language:EN
[2023/04]
Search report(s)International search report - published on:US03.03.2016
(Supplementary) European search report - dispatched on:EP12.06.2018
ClassificationIPC:A23K50/30, A23K20/189, A61K38/48, A23K10/00, // A61P1/12
[2018/28]
CPC:
A61K38/4873 (EP,KR,US); A61K9/10 (EP,KR,US); A23K20/189 (EP,KR,US);
A23K50/30 (EP,KR,US); A23K50/60 (EP,KR,US); A23K50/80 (EP,KR,US);
A61K47/12 (EP,KR,US); A61K47/183 (US); A61K47/24 (US);
A61K9/0056 (US); A61K9/0095 (EP,KR,US); A61P1/12 (EP);
A61P31/04 (EP); C12Y304/22032 (EP,US); C12Y304/22033 (EP,US);
A23V2002/00 (EP,KR,US); A23V2200/32 (KR); Y02A50/30 (EP) (-)
C-Set:
A23V2002/00, A23V2200/32 (EP,US)
Former IPC [2017/30]A23K10/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/30]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:FORMULIERUNG GEGEN DURCHFALL MIT VERHINDERUNG VON ANTIMIKROBIELLER RESISTENZ[2017/30]
English:ANTI-DIARRHEA FORMULATION WHICH AVOIDS ANTIMICROBIAL RESISTANCE[2017/30]
French:FORMULATION ANTI-DIARRHÉIQUE ÉVITANT LA RÉSISTANCE AUX ANTIMICROBIENS[2017/30]
Entry into regional phase22.03.2017National basic fee paid 
22.03.2017Search fee paid 
22.03.2017Designation fee(s) paid 
22.03.2017Examination fee paid 
Examination procedure22.03.2017Examination requested  [2017/30]
22.03.2017Date on which the examining division has become responsible
07.01.2019Amendment by applicant (claims and/or description)
23.06.2020Despatch of a communication from the examining division (Time limit: M06)
09.12.2020Reply to a communication from the examining division
22.09.2022Communication of intention to grant the patent
15.12.2022Fee for grant paid
15.12.2022Fee for publishing/printing paid
15.12.2022Receipt of the translation of the claim(s)
Opposition(s)26.10.2023No opposition filed within time limit [2024/01]
Fees paidRenewal fee
16.08.2017Renewal fee patent year 03
21.08.2018Renewal fee patent year 04
28.08.2019Renewal fee patent year 05
20.08.2020Renewal fee patent year 06
23.08.2021Renewal fee patent year 07
25.08.2022Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
MC25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SI25.01.2023
SK25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
IE24.08.2023
LU24.08.2023
BE31.08.2023
[2024/36]
Former [2024/33]AT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
MC25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SI25.01.2023
SK25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
IE24.08.2023
LU24.08.2023
Former [2024/21]AT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
MC25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SI25.01.2023
SK25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
LU24.08.2023
Former [2024/16]AT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
MC25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SI25.01.2023
SK25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2024/11]AT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SI25.01.2023
SK25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2023/50]AT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SK25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2023/49]AT25.01.2023
CZ25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RO25.01.2023
RS25.01.2023
SE25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2023/48]AT25.01.2023
EE25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RS25.01.2023
SE25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2023/46]AT25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RS25.01.2023
SE25.01.2023
SM25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2023/39]AT25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RS25.01.2023
SE25.01.2023
NO25.04.2023
GR26.04.2023
IS25.05.2023
PT25.05.2023
Former [2023/38]AT25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
PL25.01.2023
RS25.01.2023
SE25.01.2023
NO25.04.2023
GR26.04.2023
PT25.05.2023
Former [2023/37]AT25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
RS25.01.2023
SE25.01.2023
NO25.04.2023
GR26.04.2023
PT25.05.2023
Former [2023/36]AT25.01.2023
FI25.01.2023
HR25.01.2023
LT25.01.2023
LV25.01.2023
RS25.01.2023
SE25.01.2023
NO25.04.2023
PT25.05.2023
Former [2023/35]AT25.01.2023
HR25.01.2023
LT25.01.2023
RS25.01.2023
NO25.04.2023
PT25.05.2023
Former [2023/34]LT25.01.2023
RS25.01.2023
PT25.05.2023
Former [2023/33]LT25.01.2023
Documents cited:Search[X]WO8801506  (YING THOMAS KO SAI [AU]) [X] 1,5,6,10-12 * page 4, lines 17-30 * * page 5, lines 19-20 * * examples 1,5 *;
 [X]US5484609  (KO THOMAS SAI YING [AU]) [X] 1,5,6,10-12 * column 3, line 35 - column 4, line 7 ** examples 1,4 *;
 [XI]CN1548154  (WEI AO SICHUAN BIOTECHNOLOGY C [CN]) [X] 1-5,10-12 * the whole document * [I] 13-15;
 [XI]WO2008049437  (BIOFIBER DAMINO AS [DK], et al) [X] 1-4,7,10-12 * page 1, line 8 * * page 2, lines 8-30 * * page 4, lines 8-9,17-20 * * page 7, lines 4-20 * * page 20, lines 22-33 * * page 23, lines 1-18 * * page 24, line 8 * [I] 8
International search[A]US6080403  (SHIELDS JR RICHARD G [US], et al) [A] 1-15 * entire document *;
 [XY]US2006052438  (HO CHI-TANG [US], et al) [X] 9-12 * entire document * [Y] 4-8, 15;
 [A]WO2009009879  (AQUIENCE INC [CA], et al) [A] 1-15* entire document *;
 [XY]  - CHANDLER et al., "Bromelain protects piglets from diarrhea caused by oral challenge with K88 positive enterotoxigenic Escherichia coli", Gut, (19980801), vol. 43, pages 196 - 202, XP 002464839 [X] 13, 14 * . entire document * [Y] 1-8, 15
 [Y]  - GASPANI et al., "In vivo and in vitro Effects of Bromelain on PGE2 and SP Concentrations in the Inflammatory Exudate in Rats", Pharmacology, (20020501), vol. 65, pages 83 - 86, XP009500538 [Y] 1-8, 15 * . entire document *

DOI:   http://dx.doi.org/10.1159/000056191
 [A]  - MYNOTT et al., "Bromelain Prevents Secretion Caused by Vibrio cholerae and Escherichia coli Enterotoxins in Rabbit Ileum In Vitro", Gastroenterology, (19970701), vol. 113, doi:doi:10.1016/S0016-5085(97)70093-3, pages 175 - 184, XP 005688534 [A] 1-15 * . entire document *
 [A]  - MYNOTT et al., "Oral administration of protease inhibits enterotoxigenic Escherichia coli receptor activity in piglet small intestine", Gut, (19960101), vol. 38, pages 28 - 32, XP 055411985 [A] 1-15 * . entire document *
 [A]  - FAIBROTHER et al., "Escherichia coli in postweaning diarrhea in pigs: an update on bacterial types, pathogenesis, and prevention strategies", Animal Health Research Reviews., (20050601), vol. 6, doi:doi:10.1079/AHR2005105, pages 17 - 39, XP 008176046 [A] 1-15 * . entire document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.